Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co- Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.astellas.com/system/files/news/2020-01/20200114_en_1_2.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (5)
Alternatively, you can try searching for similar contracts:
